CS1002

DRUG2 trials

Sponsors

CStone Pharmaceuticals

Conditions

Advanced Solid TumorSolid Tumor, Adult

Phase 1

A Study of CS1002 in Subjects with Advanced Solid Tumors

CompletedNCT03523819

CStone PharmaceuticalsSolid Tumor, Adult

Start: 2018-04-26End: 2022-01-18Updated: 2024-09-19

A Phase I Study of CS1002 in Subjects With Advanced Solid Tumors

CompletedNCT04338724

CStone PharmaceuticalsAdvanced Solid Tumor

Start: 2019-12-27End: 2020-09-21Updated: 2021-02-21

Related Papers

A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.

2023-09-203 citations